Positioning Statements on Physician-led Switching for Biosimilar Medicines

Market review Biosimilar medicines policy 2023 - Policy… 27 September 2023 The Biosimilar Market Access Committee (Biosimilar medicines Group, a Medicines…
EMA/HMA share definitive EU-wide position on biosimilar… 19 September 2022 The Biosimilar medicines group, a Medicines for Europe sector group,…
Market review Generic medicines policy 2023 - Policy… 29 June 2023 The Generic Market Access Committee (Generic medicines Group, a Medicines…
Position Paper - Unitary SPC & Unified Mechanism for the… 13 November 2022 Open